17 results
424B3
IKT
Inhibikase Therapeutics Inc
4 Apr 23
Prospectus supplement
4:57pm
to participate in the 340B drug pricing program. The required 340B discount on a given product is calculated based on the AMP and Medicaid rebate amounts … governing drug pricing and reimbursement vary widely from country to country. For example, the European Union provides options for its member states
POS AM
IKT
Inhibikase Therapeutics Inc
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
to participate in the 340B drug pricing program. The required 340B discount on a given product is calculated based on the AMP and Medicaid rebate amounts … governing drug pricing and reimbursement vary widely from country to country. For example, the European Union provides options for its member states
424B4
l7z7f5 e3jrchi
17 Jun 21
Prospectus supplement with pricing info
4:31pm
DRS
uqo6tk03a8eol7
2 Jun 21
Draft registration statement
12:00am
10-K
0ol7cjr
31 Mar 21
Annual report
2:14pm
424B4
0ilra5ay72wc
28 Dec 20
Prospectus supplement with pricing info
6:04am
S-1
tzc39 nloxi8xi6p
23 Jul 20
IPO registration
12:28pm
DRS/A
jow4p8o0t78x4h9cea6
16 Oct 18
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next